• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRALIGHT ST MESH; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 VENTRALIGHT ST MESH; SURGICAL MESH Back to Search Results
Catalog Number 5954460
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Seroma (2069)
Date of Event 08/20/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Based on the article, no definitive conclusions can be drawn.The information is limited to what is reported in the article.The article does not report any specific device malfunction or alleged post-op complications were caused or contributed to the use of the ventralight st mesh.No lot number has been provided; therefore, a review of the manufacturing records is not possible.Seroma formation is a clinically understood potential complication of surgery/use of the device and is identified in the instructions-for-use provided with the device, as a possible complication.Note, the date of event (20-aug-2023) is considered to be a best estimate.Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
Per journal article: "management of massive flank hernia after lateral lumbar fusion: preoperative botulinum toxin injections and open repair ¿ a case report".Incisional flank hernias represent a complication after lateral lumbar spine surgery.Given the increasing rate of lateral lumbar interbody fusions, the rate of incisional flank hernias will increase.Preoperative management involved ct-guided botulinum toxin injections into the lateral abdominal wall muscles to relax and lengthen them, facilitating closure.Definitive treatment was an open flank hernia repair with mesh reinforcement, ensuring optimal myofascial re-approximation and skin closure.Conclusion at the 2-week follow-up, pain was improving, but swelling at the left flank surgical site suggested a postoperative seroma.By the 4-week follow-up, the seroma, pain, and discomfort had completely resolved, though bulging in the left lateral abdominal wall was noted.A ct scan at 2 months showed no evidence of the previous hernia defect.The patient experienced complete resolution of pain and abdominal wall defect, the use of pre-operative botulinum toxin injections prior to massive lateral flank hernia repair is recommended.Note: there is no information provided in the article indicating that the device caused or contributed to the postoperative patient complication(s).However, as postoperative complications did present and may require medical/surgical intervention we are reporting this as a serious injury mdr.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENTRALIGHT ST MESH
Common Device Name
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key23816484
Report Number1213643-2025-01217
Device Sequence Number15790308
Product Code FTL
UDI-Device Identifier00801741031625
UDI-Public(01)00801741031625
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K101851
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Literature
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/05/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number5954460
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/01/2025
Initial Report FDA Received Date12/16/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexMale
-
-